medical industry information

September 18, 2017   Source: Ddu  183 After attending Shanghai CNEF and Hospitalar in Brazil you come home and look at the pile of name cards and the masses of client information you collected. Now what? We often establish new business relationships at exhibitions such as these but the key of securing them lies in how you follow up on your clients. Ddu ( www.drugdu.com ), the leading global   pharmaceutical drugs   and   medical device products   B2B online platform, today shares with you some insight on how to organize client materials and write your first follow up development letter. I. Organize and follow up on your clients with purpose The first step is to collect as much information as possible and pay special attention to all the relevant details at the exhibition. For example, what the client is looking for, what they are most concerned about, what kind of products and suppliers they have in mind and which business partners they would like to keep. After th

How does the salesmen do the job to help the company promote the existing drug to the local market after the company makes the decision to enter the Indonesian market?It is a common problem that concerned us. As a global pharmaceutical and  medical device products  B2B pl B2B online platform, Ddu invited Sherlock Chen, a senior biotech practitioner, to talk about how to develop the Indonesian market. Sherlock Chen is engaged in the biological products industry for 20 years. He is familiar with the processes of development, registration, sales of vaccines, blood products,etc. Preparations Work Preparatory work is needed for the development of the Indonesian market, which is consistent with the development of other market. Here are the following points: Overall Research of The Country Situation To research the population and age distributions of Indonesia; To research the major drugs and morbidities of relevant diseases in Indonesia; To research the coverage of Medica

There are three major and indispensable elements in foreign trade: supply, market and clients.  As an international trade company, it’s necessary to establish good relationship with  medical device suppliers  since our goal is to collaborate with them for support in marketing and product supply.  As more and more people attach greater importance to negotiating with clients, the role of suppliers should not be overlooked. In actual fact, establishing ties with suppliers is an act of creating professional friendships and various factors come into play.  1.Professional attitude  Dealing with suppliers requires respect and professionalism as these are the building blocks for any good relationships  In our industry, there are times when certain products are in high demand. Situations such as these often lead to tense situations where clients expect you to deliver. This challenge allows you to prove your efficiency and ability to deal with pressure.  In one such situation, our clients w

November 21, 2017   Source: Ddu  261 As the largest  medical device and equipment  fair, the 49th  MEDICA  2017 was grandly held in Düsseldorf, Germany, from the 13th to the 16th of November 2017. Ddu, the leading global  pharmaceutical  and  medical device products  B2B online platform, attended the exhibition and showcased their new cost-effective way to boost cross-border medical trade, amazing everybody with advanced technology. Positive feedback from users for advanced technology MEDICA is the main attraction for all those involved in the health care industry. With its numerous special events, international conferences and forum programs, not to mention the largest and most comprehensive display of  medical device and equipment  product in the industry, MEDICA is the hub for international medical trade . Aiming to bring changes to the cross-border medical trade, Ddu showcased their latest cost-effective way to boost cross-border medical trade and was praised for  a

August 21, 2017  Source: Ddu 284 Drugdu.com(Ddu), the leading global pharmaceutical and medical device B2B online platform, reached a collaboration with Swiss SGS about Ddu Credit Verification service (RELATED: Press Conference for Ddu Credit Verification Launch). A press conference for the launch of the Ddu Credit Verification service was successfully held in Shenzhen, China on August 18, 2017. Terry Yuan, CEO of Ddu and Zhang Yunbo, deputy director of the consumer products division at SGS China, attended the press conference to officially announce their co-operation and the launch of the Ddu Credit Verification service, pioneering in a new trend for industry integrity in the cross - border medical trade. At the conference, a formal signing ceremony was held by Ddu and SGS to jointly launch the Credit Verification service, designed for the cross - border medical trade in order to create integrity for business communication between buyers and sellers by examining the key inf

According to official Ddu news, the leading global pharmaceutical and medical device B2B online platform and SGS-CSTC (Standards Technical Services Co., Ltd.) will be calling a press conference in Shenzhen, China, on August 18, 2017 to launch their strategic partnership on credit verification and kick off the Ddu Credit Verification Service officially. In recent years, the cross-border medical trade in China has seen rapid development, however due to certain factors such as lack of integrity, time lags and remote regions, it has been difficult for buyers and suppliers to determine the quality of the trade which could lead to contract fraud, counterfeit and inferior goods as well as payment delinquencies and false transaction. To tackle these problems, a signing ceremony for strategic cooperation on credit verification will be held by Ddu and SGS-CSTC to officially launch the project. Yuan Shimin, CEO of Ddu, together with high priority members across the country, will gather to

Over the past decade, the medical device industry has seen a boom in development and innovative ideas. With this innovation came a rise in the costs of  medical device products  which presents new challenges to buyers. With this in mind, we have compiled a list of 4 tips that could help you in this decision making process. 1. Assess the need for the device Medical devices and equipmen t are constantly being upgraded with new features and functionalities on an almost daily basis. With all this progress taking place it’s easy to get side tracked and lose sight of your actual objective, leading to large amounts of capital being spent on inessential products. Before making a purchase, take some time do the research. This will help you focus on your business goals, ensuring that you buy what is necessary to achieve them. 2. Budget reduction Doing this research may reveal various methods for expense reductions on medical devices and could reduce overall supply costs by as much as 10% to 20%.

As 2017 draws to a close, we look back at a year where advances in  pharmaceutical drugs  therapies brought new hope to people from across the globe. These steps forward bring with them a sense of suspense as we wait for more ground-breaking work to be accomplished in 2018.  Here is Drugdu.com’s list of medical advances that amazed. 1.  Radicava for ALS As the first new treatment to be approved by the FDA in 22 years, Radicava is first on our list of drugs. ALS (amyotrophic lateral sclerosis) also known as Lou Gehrig’s disease, is a neurodegenerative disease that reduces the functionality of muscles in the body. There are still no cures for ALS but during Radicava’s phase 3 trial, 33% of the patients who received the drug reported a slowing down of functional deterioration, meaning a longer term of independence for ALS sufferers. 2. Experimental drug for Huntington’s disease This fatal genetic disorder causes a degradation of nerve cells in the brain, affecting both physical and

3D printed  medical device products  are very high-end devices that are engaged in the process of utilizing digital models to develop a three-dimensional object.In the healthcare industry, many academic institutes make use of this technology for patient-specific treatment.The key 3D printed medical devices companies are working on strategies that would increase their market share.     In terms of income, the global 3D print  medical device and equipment  market is expected to grow at a compound annual growth rate of 17.7% during the forecast period, which is expected to reach $1.4694 billion by the end of 2026. (Source: Future Market Insights, 2016)The key companies of 3D printed medical devices in the global 3D Systems, Inc., Arcam AB, Stratasys Ltd., FabRx Ltd., EOS GmbH Electro Optical Systems, EnvisionTEC, Cyfuse Biomedical K.K., and Bio3D Technologies taking innovative creating a successful strategic plan to increase their consumer base.  Reasons 3D printing medical devices will h